A meta-analysis of the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor treatment in non-small-cell lung cancer patients.

被引：0
|
作者：
Xu, Hongmei [1 ]
Minchella, Kaitlyn [1 ]
Zhou, Diansong [1 ]
Al-Huniti, Nidal [1 ]
机构：
[1] AstraZeneca, Waltham, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_supll.e20604
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20604
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Hepatotoxicity with epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer patients: A network meta-analysis
    Wu, Ziyang
    Chen, Suhua
    Du, Xin
    Wu, Yibo
    Xie, Xiaohui
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (02) : 310 - 318
  • [2] Epidermal growth factor receptor mutations and their correlation with epidermal growth factor receptor-tyrosine kinase inhibitor therapy and association with the characteristics of patients with non-small-cell lung cancer: A meta-analysis
    Zhang, Xiao-Hang
    Li, Cheng
    Dai, Chen-Fei
    Zhou, Bao-Sen
    THORACIC CANCER, 2011, 2 (03) : 101 - 108
  • [3] IMPACT OF EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITOR TREATMENT IN ADVANCED NON-SMALL CELL LUNG CANCER: A META-ANALYSIS
    Lee, C. K.
    Brown, C.
    Gralla, R.
    Hirsh, V.
    Inoue, A.
    Gebski, V.
    Yang, C. J.
    ANNALS OF ONCOLOGY, 2012, 23 : 414 - 414
  • [4] EFFICACY OF EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR IN TREATING CHOROIDAL METASTASIS FROM NON-SMALL-CELL LUNG CANCER
    Chee, Arnold S. H.
    Mak, Andrew C. Y.
    Kam, Ka Wai
    Li, Molly S. C.
    Ho, Mary
    Brelen, Marten E.
    Chen, Li Jia
    Yip, Wilson W. K.
    Young, Alvin L.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2025, 45 (02): : 207 - 214
  • [5] Efficacy and safety of tyrosine kinase inhibitors in advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutation: a network meta-analysis
    Alanazi, Abdullah
    Yunusa, Ismaeel
    Elenizi, Khaled
    Alzarea, Abdulaziz, I
    LUNG CANCER MANAGEMENT, 2021, 10 (01)
  • [6] Efficacy of epidermal growth factor receptor tyrosine kinase inhibitor in the treatment of patients with nonsmall cell lung cancer
    Li, Xi
    Li, Wen-Bo
    Luo, Qiang
    Liu, Yuan
    MEDICINE, 2023, 102 (38) : E35081
  • [7] Does metformin improve the efficacy of standard epidermal growth factor receptor-tyrosine kinase inhibitor treatment for patients with advanced non-small-cell lung cancer?
    Lin, Zhangyu
    Li, Guangchen
    Xu, Xinyu
    Mei, Jiandong
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2021, 32 (01) : 73 - 76
  • [8] Small Molecule Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Non Small Cell Lung Cancer Treatment
    Schettino, Clorinda
    Bareschino, Maria Anna
    Maione, Paolo
    Rossi, Antonio
    Ciardiello, Fortunato
    Gridelli, Cesare
    CURRENT CANCER THERAPY REVIEWS, 2007, 3 (04) : 226 - 235
  • [9] Is epidermal growth factor receptor tyrosine kinase inhibitor in combination with cytotoxic chemotherapy a better treatment option for patients with EGFR-mutated non-small-cell lung cancer?
    Takahashi, Kosuke
    Saito, Hiroshi
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 98 - 101
  • [10] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment in Patients With EGFR Wild-Type Non-Small-Cell Lung Cancer: The Never-Ending Story
    Gelsomino, Francesco
    Agustoni, Francesco
    Niger, Monica
    Valota, Marika
    Haspinger, Eva R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26) : 3291 - 3293
12345